Expert panelists provide payer considerations pertaining to the treatment of MDD.
October 31st 2022EP. 1: Unmet Needs in Treatment of MDD
Michael Rothrock, MBA, MHA, and H. Eric Cannon, PharmD, FAMCP, open a discussion surrounding payer considerations relating to the treatment of major depressive disorder (MDD).
October 31st 2022EP. 2: MDD Treatment Landscape
Expert panelists discuss the lack of diversity among available treatment options for MDD.
November 7th 2022EP. 3: Potential Consequences of Recurrent or Poorly Controlled MDD
Consequences attributed to poorly controlled and recurrent MDD are evaluated by Michael Rothrock, MBA, MHA, and H. Eric Cannon, PharmD, FAMCP.
November 7th 2022EP. 4: Burden of Treatment Failure in MDD
Major depressive disorder treatment failure can lead to subsequent costs and poor outcomes, affecting payer considerations in the treatment landscape.
November 14th 2022EP. 5: Importance of Early Effective Treatment of MDD
Key opinion leaders discuss the importance of early effective treatment for patients with MDD.
November 14th 2022EP. 6: Evaluating MDD Treatment Attributes
Panelists provide their key considerations when determining appropriate treatment options for patients with major depressive disorder.
November 21st 2022EP. 7: Considerations for Newly Launched MDD Treatments
Drs Cannon and Rothrock provide insights into their process for defining value among newly launched MDD treatments.
November 21st 2022EP. 8: Healthcare Disparities Within Major Depressive Disorder
Managed care experts discuss health disparities among various patient populations affected by MDD.
November 28th 2022EP. 9: MDD Treatment Disparities Across Patient Populations
Expert panelists explore prevalence and disparities of MDD across patient populations.
November 28th 2022EP. 10: Social Determinants of Health in MDD
Key social determinants affecting MDD are evaluated by Michael Rothrock, MBA, MHA, and H. Eric Cannon, PharmD, FAMCP.
December 5th 2022EP. 11: Impact of COVID-19 on Demand for Mental Health Services
Jay Weaver, PharmD, MPH, and Mona Chitre, PharmD, CGP, discuss the increased demand for mental health services since the COVID-19 pandemic.
December 5th 2022EP. 12: Health Care Disparities Within Major Depressive Disorder (MDD)
Payers provide insights to health care disparities currently impacting patients with major depressive disorder (MDD).
December 12th 2022EP. 13: MDD Treatment Disparities Across Patient Populations: Part 2
Drs Chitre and Weaver explore social and health care disparities more prominently affecting various MDD patient populations.
December 12th 2022EP. 14: Social Determinants of Health in MDD: Part 2
Key social determinants of health impacting MDD are discussed by expert payer panelists.
December 19th 2022EP. 15: Population Health Approach in MDD
Drs Weaver and Chitre illustrate a population health approach strategy for MDD.
December 19th 2022EP. 16: Factors Affecting MDD Treatment Adherence
Expert panelists consider factors affecting treatment adherence for patients with MDD.
January 3rd 2023EP. 17: Supporting Adherence for Patients with MDD
Drs Weaver and Chitre share strategies to support MDD treatment adherence across their patient populations.
January 3rd 2023EP. 18: Aligning MDD Treatment Goals for Payers and Patients
Drs Weaver and Chitre discuss aligning key considerations for payers and goals of therapy for patients in the treatment of MDD.
January 10th 2023EP. 19: The Impact of Early Effective Treatment in MDD
Early effective treatment strategies can have a significant impact on long-term effects for patients with MDD.
January 10th 2023EP. 20: Key Contributors to Long-term Outcomes for Patients With MDD
Drs Chitre and Weaver share their finals thoughts, highlighting key contributors to long-term outcomes for patients with major depressive disorder.
